When.com Web Search

  1. Ads

    related to: xifaxan generic cost

Search results

  1. Results From The WOW.Com Content Network
  2. Medicare Part D coverage for Xifaxan - AOL

    www.aol.com/medicare-part-d-coverage-xifaxan...

    Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent ...

  3. Does Medicare Cover Rifaximin (Xifaxan)? - AOL

    www.aol.com/does-medicare-cover-rifaximin...

    According to the drug’s manufacturer, 100% of Medicare Part D beneficiaries have some coverage for Xifaxan for either use. Medicare may also cover rifaximin (Xifaxan) for traveler’s diarrhea ...

  4. Rifaximin - Wikipedia

    en.wikipedia.org/wiki/Rifaximin

    Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...

  5. Rifamycin - Wikipedia

    en.wikipedia.org/wiki/Rifamycin

    Lepetit filed for patent protection of Rifamycin B in the UK in August 1958, and in the US in March 1959. The British patent GB921045 was granted in March 1963, and U.S. Patent 3,150,046 was granted in September 1964. The drug is widely regarded as having helped conquer the issue of drug-resistant tuberculosis in the 1960s.

  6. GoodRx - Wikipedia

    en.wikipedia.org/wiki/GoodRx

    GoodRx Holdings, Inc., is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. [3] GoodRx checks drug prices at more than seventy-five thousand pharmacies in the United States.

  7. Bausch wins US appeal to block Alvogen generic of diarrhea drug

    www.aol.com/news/bausch-wins-us-appeal-block...

    A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029.

  1. Ad

    related to: xifaxan generic cost